Visual Benefits Of Anti-VEGF Therapy May Diminish Upon Extended Dosing
Long-term outcomes of anti-VEGF therapy for neovascular age-related macular degeneration suggest that eyes with good visual acuities require long-term regular dosing, according to a presentation here.